Theta Burst Transcranial Focused Ultrasound as a Novel Treatment for Cervical Dystonia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorRobert Chen

About this trial

This study is a single-blinded, randomized control study that aims to recruit 48 participants. Participants will be "randomized" into one of the study arms of the study: active stimulation to GPi, active stimulation to DN, or sham stimulation. The purpose of the study is to look into the effects of LIFUS in patients with cervical dystonia. The participation will include seven study visits, at least 24 hours apart. All study visits will take place at TWH. The first visit is a screening visit. Visits 2-6 will be on consecutive days. Visit 7 will be a week from Visit 6 or from your last day of LIFUS, whichever comes first.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18 - 90 years of age

Confirmed diagnosis cervical dystonia

3 months since last botulinum toxin injection

Stable medications in the past month

Disqualifiers

Has neurological disorder other than dystonia (such as compressive neuropathy, limb trauma, epilepsy)

Cognitive deficits leading to inability to understand study purposes and risks as well as the consent information without legal trustee

Presence of metal implanted in body that is contraindicated in MRI

Pregnancy

Trial design

Design model

Single group

Treatments tested in this trial

  • LIFUS - GPi Active

    Device

    Bilateral thetaburst LIFUS stimulation to the globus pallidus

  • LIFUS - DN Active

    Device

    Bilateral thetaburst LIFUS stimulation to dentate nucleus

  • LIFUS - Sham

    Device

    Bilateral sham (placebo) LIFUS stimulation

Treatment groups

48 Participants
are divided into 3 treatment groups
Group A: LIFUS - GPiExperimental treatment 1 intervention
Group B: LIFUS - DNExperimental treatment 1 intervention
Group C: LIFUS - ShamSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)

Dystonia Assessment

Time frame
from Visit 2 prior to stimulation to up to 2 weeks
2

Resting State Functional MRI

Time frame
from Visit 2 prior to stimulation to up to 1 week
3

Dystonia non-motor symptoms questionnaire (DNMSQuest)

Dystonia Assessment

Time frame
from Visit 2 prior to stimulation to up to 2 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Robert Chen

Lead sponsor

University Health Network, Toronto

Sponsor institution